Ksilink for investors
Foundations & patient organizations
Discover most efficient drugs, improving lives of patients and their families is our incitement and motivation. Especially for diseases with high medical need such as Myopathies, Psychiatric disorders, Neurodegeneration and Cancer. Supporting Ksilink by investing into our dedicated Fund allows the intiation of new translational projects and their further development in these fields. Each project involves Europe’s top specialists and platforms from hospitals, universities and the pharmaceutical industry.
Business Angels & Venture Capital
Addressing fields with high medical needs, Ksilink delivers first-in-class drugs with high chances of success for clinical development and market entry. Our program specific spin-offs start with a strong IPR portfolio, access to patient cohorts and a dedicated team of experts. Investing in one of these spin-offs means significant return on investment through milestone and royalty payment.